logo-loader
Instem PLC

Instem flags share sale

A total of 1.66mln shares are being sold to “to satisfy market demand and broaden the institutional investor base”

pricing screen
N+1 Singer Capital Markets is organising what’s called an accelerated bookbuild

Instem PLC (LON:INS) said shareholders including chairman David Gare and non-executive director David Sherwin plan to sell stock in the IT company “to satisfy market demand and broaden the institutional investor base”.

A total of 1.6mln shares (the equivalent of 10.2% stake) are being sold at “not less than” 290p a share.

“Following the placing, the selling shareholders have no intention of making any further sales of ordinary shares for at least the next 12 months,” Instem said.

N+1 Singer Capital Markets is organising what’s called an accelerated bookbuild to market the stock to institutional investors.

Quick facts: Instem PLC

Price: £3.84

Market: AIM
Market Cap: £62.5 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Instem PLC named herein, including the promotion by the Company of Instem PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Instem seeing all clients place orders as healthcare market stays buoyant

Phil Reason, chief executive of healthcare AI software group Instem PLC (LON:INS), says business was strong across all areas of the group in the first six months of 2019. Even a change from licences to a SaaS or pay-as you-use model has gone smoothly, he says, with cash inflows strong...

3 weeks, 5 days ago

2 min read